Coherus Oncology
CHRS
CHRS
106 hedge funds and large institutions have $576M invested in Coherus Oncology in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 54 increasing their positions, 21 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
27% less capital invested
Capital invested by funds: $793M → $576M (-$217M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
106
Holding in Top 10
–
Calls
$6.23M
Puts
$3.15M
Top Buyers
| 1 | +$52.1M | |
| 2 | +$7.04M | |
| 3 | +$5.94M | |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$4.85M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$4.35M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$9.57M | |
| 3 | -$8.91M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$8.24M |
| 5 |
BM
Bridger Management
New York
|
-$6.97M |